methotrexate has been researched along with Duncan Disease in 228 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (0.88) | 18.7374 |
1990's | 16 (7.02) | 18.2507 |
2000's | 36 (15.79) | 29.6817 |
2010's | 111 (48.68) | 24.3611 |
2020's | 63 (27.63) | 2.80 |
Authors | Studies |
---|---|
Iga, N; Imamura, Y; Ishizaki, M; Kawai, H; Miyauchi, S; Mizuno, D; Nishi, H; Suemori, K; Uno, F; Yoshida, R | 1 |
Banko, A; Cirkovic, A; Despotovic, A; Grk, M; Jeremic, I; Lazarevic, I; Miljanovic, D | 1 |
Fujioka, T; Hosoya, T; Kubota, K; Kumaki, Y; Mori, M; Nakagawa, T; Oda, G; Ogawa, A; Onishi, I; Uetake, H | 1 |
Ishikawa, T; Maeda, Y; Makita, M; Murakami, H; Nagakita, K; Shinno, Y; Sunami, K; Yoshino, T; Yoshioka, T | 1 |
Chayama, K; Fujitaka, K; Hamada, H; Hattori, N; Horimasu, Y; Ito, N; Iwamoto, H; Masuda, T; Miyamoto, S; Nakashima, T; Sakamoto, S; Yamaguchi, K | 1 |
Kawashima, S; Kayamori, K; Kurabayashi, T; Kuribayashi, A; Sakamoto, J; Tomisato, H; Watanabe, H | 1 |
Ando, J; Ando, M; Komatsu, N; Ota, Y; Yasuda, H; Yoshida, S | 1 |
Altshuler, E; Franke, AJ; Holland, E | 1 |
Kumagai, J; Mochimatsu, Y; Ohgaki, F; Paku, S; Shuto, T; Takemoto, Y; Tatezuki, J | 1 |
Dobashi, H; Kadowaki, N; Kameda, T; Kato, M; Mino, R; Mitamura, K; Miyagi, T; Mizusaki, M; Nakashima, S; Norikane, T; Shimada, H; Sugihara, K; Wakiya, R; Yamamoto, Y | 1 |
Teratani, Y; Watanabe, T | 1 |
Nakano, K | 1 |
Urata, Y | 1 |
Lefor, AK; Miyato, H; Omameuda, T; Sata, N | 1 |
Daa, T; Iwasaki, H; Kadowaki, M; Kawauchi, S; Kimura, S; Ogata, M; Oshiro, Y; Sakata, T; Takamatsu, Y; Takeshita, M; Wang, Z | 1 |
Ando, K; Ichinose, K; Imaizumi, Y; Itonaga, H; Kato, T; Miyazaki, Y; Miyoshi, H; Ohshima, K; Sato, S; Sawayama, Y | 1 |
D'Angelis, C; Powell, J; Quaye, EH | 1 |
Chow, TK | 1 |
Kato, H; Kohsaka, H; Misumi, K; Suzuki, M | 1 |
Kawamoto, H; Koshima, I; Shimbo, K | 1 |
Ichikawa, A; Koike, R; Mori, T; Nagao, T; Nogami, A; Okada, K; Sakashita, C; Tanaka, K; Tohda, S; Umezawa, N; Umezawa, Y; Yamamoto, K; Yamamoto, M; Yasuda, S; Yoshifuji, K | 1 |
Fisher, R; Ieremia, E; Macklin, PS; Matin, RN; Stonard, C | 1 |
Asakura, S; Tanaka, T; Ueda, Y; Yano, T | 1 |
Hirose, T; Hiruma, M; Tsuboi, K | 1 |
Apfel, LS; Cuoco, JA; In, A; Rogers, CM; Stopa, BM; Stump, MS | 1 |
Kizaki, M; Tokuhira, M | 1 |
Bredemeier, M; Busato, VB; da Silveira, RG; de David Cruz, C; Provenzi, VO; Ritter, CG; Zamboni, S | 1 |
Saito, S; Takeuchi, T | 1 |
Asano, N; Elsayed, AA; Kato, S; Kohno, K; Nakamura, S; Sakakibara, A; Satou, A; Suzuki, Y; Takahara, T | 1 |
Honda, M; Kakimaru, H; Kondo, M; Moriyama, M; Murakawa, Y; Onoda, K; Sugiura, T; Watanabe, Y | 1 |
Maruyama, T; Sako, A; Suzuki, S; Ueda, K | 1 |
Fujino, Y; Hanami, K; Kubo, S; Miyagawa, I; Nakano, K; Nakayamada, S; Nawata, A; Saito, K; Tanaka, Y | 1 |
Abe, I; Masamune, A; Shiga, H | 1 |
Carreras, J; Kikuti, YY; Kondo, Y; Moriya, K; Nakamura, N; Shiraiwa, S | 1 |
Amano, K; Anan, T; Higashi, M; Kimura, Y; Kizaki, M; Momose, S; Nakaseko, R; Sagawa, M; Tabayashi, T; Takahashi, Y; Tamaru, JI; Tanaka, Y; Tokuhira, M; Tomikawa, T; Watanabe, J | 1 |
Inoue, J; Iwata, T; Kakazu, E; Masamune, A; Ninomiya, M; Sano, A; Tsuruoka, M | 1 |
Cillo, JE; Khan, CM; Rice, J; Samhouri, Y; Taliaferro, A | 1 |
Akizuki, S; Fujimoto, M; Hashimoto, M; Hishizawa, M; Ishida, A; Kitagori, K; Murakami, K; Nakashima, R; Ohmura, K; Shindo, T; Tanaka, M; Tsuji, H; Yoshifuji, H | 1 |
Gion, Y; Komatsubara, Y; Kuroda, K; Naoi, Y; Nishizaki, K; Orita, Y; Sasaki, T; Sato, Y; Tachibana, T; Wani, Y | 1 |
Fujii, T; Harigai, M; Kaneko, Y; Kuramoto, N; Nakano, K; Saito, K; Saito, R; Saito, S; Sasaki, S; Sugimoto, N; Suzuki, Y; Takada, H; Tanaka, M; Tanaka, Y | 1 |
Mochizuki, K; Nakamura, S; Oishi, N; Sato, Y; Satou, A; Suzuki, Y; Tabata, T; Tahara, I; Takahara, T; Tsuzuki, T; Yoshino, T | 1 |
Goto, M; Iguchi, M; Kaito, S; Koyama, H; Moriyoshi, K; Okuno, Y | 1 |
Fujii, T; Harigai, M; Ito, H; Kaneko, Y; Kuramoto, N; Nakano, K; Saito, K; Saito, R; Saito, S; Sasaki, S; Sugimoto, N; Suzuki, Y; Takada, H; Tanaka, M | 1 |
Aoyanagi, N; Endo, D; Kumazawa, K; Nagai, T; Nomura, M; Ono, H; Shimizu, A; Sumiya, R | 1 |
Harigai, M; Honda, S; Inoue, E; Kihara, M; Konda, N; Majima, M; Nanki, T; Sakai, R; Takada, H; Takeuchi, T; Yajima, N; Yamamoto, K | 1 |
Goto, Y; Imamura, M; Kawahata, K; Nagafuchi, H; Sakurai, K; Shibata, T; Suzuki, S; Suzuki, T; Yamasaki, Y | 1 |
Fujii, T; Harigai, M; Kaneko, Y; Kuramoto, N; Nakano, K; Saito, K; Saito, R; Saito, S; Sasaki, S; Sugimoto, N; Suzuki, Y; Takada, H; Tanaka, M | 2 |
Hanai, S; Ichijo, M; Kawashima, I; Kobayashi, K; Nakagomi, D | 1 |
Fuji, S; Ohmoto, A | 1 |
Brandl, U; Feller, A; Frieling, D; von Wichert, G; Wernecke, M | 1 |
Fujimoto, M; Haga, H; Okada, M; Okuno, A; Takai, T | 1 |
Banno, S; Hanamura, I; Ito, Y; Iwagaitsu, S; Kohno, K; Nakamura, S; Nobata, H; Satou, A; Takahara, T; Takahashi, E; Takami, A; Tsuzuki, T; Watanabe, D | 1 |
Akita, H; Hirata, C; Kenzaka, T | 1 |
Anazawa, U; Aoyama, R; Kamio, S; Sasaki, A; Watanabe, I | 1 |
Burg, MR; Schneider, SW | 1 |
Akashi, K; Asaoku, H; Ayano, M; Fujisaki, T; Harada, T; Iwasaki, H; Kato, K; Kohno, K; Mitoma, H; Miyamoto, T; Miyamura, T; Miyoshi, H; Mori, Y; Muta, T; Niiro, H; Ohshima, K; Oryoji, K; Oshiro, Y; Sakamoto, A; Sawabe, T; Takase, K; Takeshita, M; Urata, S; Yamamoto, H; Yoshimoto, G | 1 |
Cai, K; He, J; Manolios, N; Sturgess, A; Taper, J; Williamson, L; Wong, P | 1 |
Inoue, H; Obama, K; Tabuchi, T | 1 |
Furukawa, M; Kachi, H; Kawaratani, H; Matsuura, K; Mitoro, A; Osaki, Y; Ozutsumi, T; Sawada, Y; Takagi, H; Tsuji, Y; Yamao, J; Yoshiji, H | 1 |
Fu, HY; Hu, XM; Liu, TB; Liu, YQ; Shen, JZ; Yin, Y; Zhang, LH | 1 |
Dharnidharka, VR; Hayashi, RJ; Semkiu, KM | 1 |
Chen, F; Chen, J; Gong, Y; Li, X; Luo, L; Ma, Y; Shi, C; Sun, Y; Wang, L; Xu, Z | 1 |
Hamaguchi, M; Kitamura, N; Kobayashi, H; Nagasawa, Y; Sugiyama, K; Takei, M | 1 |
Fujimoto-Hirakawa, Y; Fukuda, W; Iwai, T; Kobayashi, T; Kuriyama, K; Kuroda, J; Matsumoto, Y; Mizutani, S; Nagata, H; Nishikawa, R; Ohshiro, M; Shimura, Y; Tsukamoto, T; Uchiyama, H; Yamamoto-Sugitani, M | 1 |
Amano, K; Anan-Nemoto, T; Higashi, M; Kimura, Y; Kizaki, M; Momose, S; Okuyama, A; Tabayashi, T; Takahashi, Y; Tamaru, JI; Tanaka, Y; Tokuhira, M; Tomikawa, T; Watanabe, R | 1 |
Gion, Y; Iwaki, N; Nishida, K; Orita, Y; Sato, Y; Tachibana, T; Takata, K; Takeuchi, M; Yoshino, T | 1 |
Kitakaze, H; Matsushita, M; Minato, N; Mori, N; Okada, K; Yoshioka, T | 1 |
Furudate, K; Kobayashi, W; Narita, N; Satake, A | 1 |
Aisa, Y; Amano, Y; Arakaki, H; Hirano, M; Ito, C; Nakazato, T; Osada, Y; Takanashi, S | 1 |
Ishibashi, S; Kizawa, M; Ohkubo, T; Sanjo, N; Sato, N; Toide, N; Yokota, T | 1 |
Kaneko, Y | 1 |
Harigai, M | 1 |
Amano, K; Anan-Nemoto, T; Higashi, M; Kizaki, M; Momose, S; Mori, T; Okamoto, S; Okuyama, A; Saito, S; Shimizu, T; Suzuki, K; Takeuchi, T; Tamaru, JI; Tokuhira, M | 1 |
Huggins, AB; Kim, C; Rabinowitz, MP | 1 |
Fujio, K; Fukayama, M; Harada, H; Iwasaki, Y; Kanda, H; Kubo, K; Kurokawa, M; Nagafuchi, Y; Nakamura, F; Sasaki, O; Shibuya, M; Shinozaki-Ushiku, A; Shoda, H; Sumitomo, S; Takeshima, Y; Tateishi, S; Tsukui, D; Yamamoto, K | 1 |
Hirota, S; Matsuda, I | 1 |
Chin, YP; Lai, WF; Liu, CW; Tsai, CY | 1 |
Aota, Y; Fujiwara, K; Gotoh, A; Honda, T; Kimura, S; Nonaka, T; Okuda, Y; Sakurai, M; Wakabayashi, Y; Watanabe, T; Yokoyama, T | 1 |
Furukawa, S; Hayashida, JN; Kawano, S; Kiyoshima, T; Matsubara, R; Moriyama, M; Nakamura, S; Ogata, KI; Oobu, K; Sako, S | 1 |
Daa, T; Kohno, K; Moroga, Y; Nashimoto, Y; Ogata, M; Saburi, M; Shirao, K; Takano, K; Yoshida, N | 1 |
Mottok, A; Rosenwald, A | 1 |
Callen, JP; Maderal, AD; Malone, JC | 1 |
Eso, Y; Katsuragi, K; Matsuura, M; Sawada, K; Seno, H; Shirakawa, K; Uza, N | 1 |
Amano, K; Kameyama, K; Kaneko, Y; Mori, T; Okamoto, S; Saito, S; Shimizu, T; Suzuki, K; Takeuchi, T; Tamaru, JI; Tokuhira, M; Yamaoka, K; Yoshimoto, K | 1 |
Aisa, Y; Arakaki, H; Hirano, M; Ito, C; Mori, T; Nakazato, T; Osada, Y; Takanashi, S | 1 |
Fujii, T; Harigai, M; Kameda, H; Kanbe, K; Koike, R; Nakajima, A; Sagawa, A; Suzuki, Y; Tomita, T | 1 |
Hagihara, M; Hua, J; Ide, S; Inoue, M; Mese, T; Ohara, S | 1 |
Ebisawa, K; Funamizu, K; Koya, J; Kurokawa, M; Miyagaki, T; Nakamura, R; Oka, T; Sato, S; Sugaya, M | 1 |
Irie, T; Kanno, T; Kimura, S; Migita, K; Odajima, H; Suzuki, E | 1 |
Hatanaka, Y; Hokkoku, K; Kikuchi, Y; Sonoo, M; Tashiro, H; Uchida, Y | 1 |
Kikuchi, N; Koda, M; Kono, M; Murakami, K; Shimizu, T; Tanaka, H; Uesugi, M; Yamazaki, M | 1 |
Matsuzaki, Y; Minakawa, S; Nakano, H; Sagara, C; Sawamura, D; Takiyoshi, N | 1 |
Ishigaki, S; Kameyama, H; Kameyama, K; Kanai, T; Kawaida, M; Masaoka, T; Mori, T | 1 |
Baba, S; Enomoto, N; Fujisawa, T; Furuhashi, K; Hozumi, H; Inui, N; Karayama, M; Nakamura, Y; Suda, T; Suzuki, Y; Tsuchiya, K; Yasui, H | 1 |
Kamran, M; Ross, Y | 1 |
Banno, S; Hanamura, I; Ito, Y; Katsuno, T; Nakamura, S; Nobata, H; Satou, A; Takahara, T; Takahashi, E; Takami, A; Tsuzuki, T; Ueda, R | 1 |
Arai, H; Kawamura, M; Miyoshi, S; Nagase, H; Ohta, K; Ota, Y; Sasajima, Y; Sugimoto, N; Ujino, M; Yamaguchi, M | 1 |
Fukao, A; Horikawa, S; Ikeue, T; Kawachi, H; Noguchi, S; Sugita, T; Tajiri, T; Tanaka, E; Terashita, S; Yoshida, H | 1 |
Kariya, S; Makihara, S; Matsumoto, J; Naito, T; Nishizaki, K; Noda, Y; Noujima-Harada, M; Ohara, N; Okano, M; Yoshino, T | 1 |
Fukushima, K; Iguchi, A; Kaneyuki, D; Nakajima, H; Sato, T; Tokunaga, C | 1 |
Funakoshi, K; Takahashi, K; Terai, S; Watanabe, S | 1 |
Amano, K; Higashi, M; Kimura, Y; Kizaki, M; Momose, S; Mori, T; Okamoto, S; Saito, S; Shimizu, T; Suzuki, K; Takeuchi, T; Tamaru, JI; Tokuhira, M | 1 |
Kawasaki, T; Kohno, K; Miyoshi, H; Nakamura, S; Ohshima, K; Sato, Y; Satou, A; Shimada, K; Suzuki, Y; Tabata, T; Takahara, T; Tsuzuki, T; Yamashita, D; Yoshino, T | 1 |
Fukushima, M; Inokuma, T; Shimeno, N; Toyonaga, H | 1 |
Ichikawa, A; Imaizumi, Y; Kato, K; Kawamoto, K; Kizaki, M; Kurita, D; Miyoshi, H; Muto, R; Nagafuji, K; Ohshima, K; Sasaki, Y; Sato, K; Seki, R; Shimono, J; Tamaru, JI; Tokuhira, M; Yamada, K | 1 |
Kaplan, R; Lee, M; Nguyen, KA | 1 |
Morishige, S; Murai, S; Osumi, K; Oto, I; Sakimoto, Y; Tajima, Y; Takenoya, T; Tamura, E; Yabe, N; Yoshikawa, T | 1 |
Kitagawa, I; Kudo, M; Kumagae, T; Ono, R; Teshima, S; Uojima, H; Yoshizawa, M | 1 |
Nakamura, S; Satou, A; Tsuzuki, T | 1 |
Kizaki, M; Tamaru, JI; Tokuhira, M | 1 |
Fujikawa, K; Kawakami, A; Matsumoto, K; Matsuo, E; Mizokami, A; Nakashima, M; Okamoto, M; Sakaguchi, R; Shin-Ya, K; Uchida, T | 1 |
Matsuda, R; Miyaza, S; Motoyama, Y; Nakagawa, I; Nakamura, M; Nakase, H | 1 |
Abe, K; Eguchi, M; Endo, Y; Furuyama, M; Hashisako, M; Ichinose, K; Igawa, T; Iwamoto, N; Kanetaka, K; Kawakami, A; Kawashiri, SY; Kobayashi, S; Koga, T; Miyazaki, Y; Nakamura, H; Niino, D; Okamoto, M; Origuchi, T; Sato, S; Shimizu, T; Sumiyoshi, R; Tabuchi, M; Takatani, A; Tamai, M; Toyama, S; Tsuji, S | 1 |
Fujisaki, T; Kondo, S; Okamura, S; Oshiro, Y; Suematsu, E; Takeshita, M; Tamura, K; Tanimoto, K; Yamada, K; Yoshimoto, G | 1 |
Arakawa, F; Ichikawa, A; Ishibashi, Y; Kimura, Y; Kiyasu, J; Miura, O; Miyoshi, H; Nakashima, S; Niino, D; Ohshima, K; Sato, K; Sugita, Y; Takeuchi, M; Yoshida, M | 1 |
Dhamija, R; Nelson, A; Nickels, K | 1 |
Fukushima, M; Katayama, Y; Kotani, A; Kura, Y; Sawada, U; Yokose, N; Yoshino, A | 1 |
Blanchart, K; Chantepie, S; Charbonneau, P; Du Cheyron, D; Galateau-Salle, F; Paciencia, M; Seguin, A; Terzi, N | 1 |
Hanakawa, H; Nishizaki, K; Orita, Y; Sato, Y; Uno, K; Yoshino, T | 1 |
Sumi, T | 1 |
Harada, A; Hodohara, K; Horinouchi, A; Ishida, M; Iwai, M; Kagotani, A; Nakanishi, R; Okabe, H; Okuno, H; Yoshida, K; Yoshida, T; Yoshii, M | 1 |
Fujii, T; Fujimoto, M; Haga, H; Imura, Y; Kawabata, D; Kitano, T; Kondo, T; Maekawa, T; Matsuda, F; Mimori, T; Miura, Y; Nakashima, R; Nishikori, M; Ohmura, K; Saji, H; Takaori-Kondo, A; Terao, C; Yamakawa, N; Yoshifuji, H; Yukawa, N; Yurugi, K | 1 |
Fujioka, Y; Kamma, H; Koji, H; Nakabayashi, K; Yamada, A; Yazawa, T | 1 |
Aoyagi, H; Gozu, K; Hasegawa, K; Isogai, J; Kaneko, J; Maejima, S; Matsui, T; Yoshida, T | 1 |
Enomoto, Y; Kimura, H; Koyama, N; Matsuda, M; Nakamura, A; Obayashi, C; Ota, H; Tomoda, K; Yamamoto, Y; Yoshikawa, M | 1 |
Johnson, RJ; Owen, RG; Sadasivam, N | 1 |
Kaneko, H; Kano, T; Mimori, A; Takahashi, Y; Yamashita, H; Yoshida, Y | 1 |
Kanno, M; Masumoto, J; Miyazaki, T; Mokuda, S; Saeki, Y; Takasugi, K | 1 |
Dobashi, H; Fukumoto, T; Haba, R; Imataki, O; Inoo, M; Izumikawa, M; Kameda, T; Kawakami, K; Kurata, N; Mano, S; Matsunaga, T; Mitsunaka, H; Miyatake, N; Nakashima, S; Onishi, H; Onishi, I; Shimada, H; Susaki, K; Takeuchi, Y | 1 |
Hirooka, S; Ishikawa, T; Katagi, H; Kuwano, K; Okuda, K; Takagi, M; Yamakawa, H; Yoshida, M | 1 |
Chan, HN; Ha, CY; Lai, HK; Law, MF; Leung, C; Ng, C; Yeung, YM; Yip, SF | 1 |
Harada, H; Ishii, Y; Kudoh, M; Matsumoto, K; Omura, K; Sato, Y | 1 |
Hashimoto, K; Kinoshita, H; Nagao, T; Saito, T | 1 |
Chin, CC; Heerema-McKenney, A; Iagaru, A; Mahapatra, S; Twist, CJ | 1 |
Amano, K; Higashi, M; Kimura, Y; Kizaki, M; Mori, S; Nemoto, T; Okuyama, A; Sagawa, M; Sakai, R; Tabayashi, T; Tamaru, J; Tokuhira, M; Tomikawa, T; Watanabe, R | 1 |
Oiwa, H | 1 |
Aiba, K; Inui, Y; Ito, M; Itoh, T; Matsuoka, H; Minami, H; Murayama, T; Okamura, A; Shimada, T; Takeuchi, M; Yakushijin, K; Yamamoto, K; Yano, S | 1 |
Abe, K; Asano, T; Hashimoto, Y; Kanno, Y; Kobayashi, H; Ohira, H; Okai, K; Takahashi, A; Takasumi, M; Watanabe, H | 1 |
Furukawa, S; Hashimoto, S; Ito, S; Kawaguchi, T; Kawajiri, C; Kuwabara, S; Nakaseko, C; Ota, S; Shimizu, N; Takagi, T; Takeda, Y; Tanaka, H | 1 |
Hasegawa, H; Ishizaki, J; Matsumoto, T; Onishi, S; Sada, E; Suemori, K; Sugita, A; Yasukawa, M | 1 |
Kadota, C; Kimura, S; Kurogi, K; Miyahara, M; Ureshino, H | 1 |
Fukayama, M; Koda, K; Tajima, S; Takanashi, Y | 1 |
Åhlin, A; Hagelberg, S; Olsson, RF; Ringdén, O; Schiller, B; Truedsson, L | 1 |
Abe, A; Ishikawa, H; Ito, S; Murasawa, A; Wakaki, K | 1 |
Bessho, K; Mishima, S; Takahashi, K; Tomioka, T | 1 |
Fujiwara, M; Ikeda, K; Io, K; Kinoshita, T; Miyoshi, T; Nagai, K; Nakamura, T; Someda, H; Uose, S | 1 |
Kamiya, Y; Suda, T; Toyoshima, M | 1 |
Fujitsu, Y; Kimura, K; Kobayashi, Y; Muta, H; Shinkawa, K; Sonoda, KH | 1 |
Chosidow, O; Cordel, N; Delfau, MH; Do-Pham, G; Haioun, C; Ingen-Housz-Oro, S; Moroch, J; Ortonne, N | 1 |
Emoto, K; Kaneko, Y; Kasahara, H; Kikuchi, J; Kubo, A; Okamoto, S; Takeuchi, T | 1 |
Dobashi, H; Kameda, T | 1 |
Charpentier, C; Cheddani, H; Dauchet, L; Dupas, JL; Fumery, M; Gower-Rousseau, C; Marie Bouvier, A; Pariente, B; Peyrin-Biroulet, L; Savoye, G | 1 |
Hattori, N; Hirata, K; Kikuchi, Y; Kobayashi, K; Manabe, O; Oyama-Manabe, N; Tamaki, N; Toyonaga, T; Watanabe, S | 1 |
Chuma, M; Doba, N; Fukuda, H; Hara, K; Ishii, Y; Maeda, S; Matsumoto, R; Nozaki, A; Numata, K; Tanaka, K | 1 |
Nakamura, H; Shibata, Y; Takeda, T | 1 |
Hiramatsu, S; Katsuyama, E; Katsuyama, T; Kawabata, T; Kiguchi, T; Miyake, K; Miyawaki, Y; Morishita, M; Ohashi, K; Sada, KE; Sunahori-Watanabe, K; Takano-Narazaki, M; Toyota-Tatebe, N; Wada, J; Watanabe, H; Yan, M; Zeggar, S | 1 |
Ejima-Yamada, K; Fujisaki, T; Fukushige, T; Kojima, M; Mihashi, Y; Okamura, S; Oshiro, Y; Shibuya, K; Takeshita, M; Tamura, K | 1 |
Boice, J; Colombel, JF; Cornillie, F; D'Haens, G; Ghosh, S; Hommes, DW; Huang, Z; Huyck, S; Lindgren, S; Panes, J; Prantera, C; Reinisch, W | 1 |
Kuroshima, Y; Nakamura, Y; Tamura, R | 1 |
Kaneko, Y; Saito, S; Takeuchi, T; Tokuhira, M; Yamaoka, K | 1 |
Barabareschi, M; Berti, A; Bortolotti, R; Felicetti, M; Guella, A; Morelli, L; Paolazzi, G; Peccatori, S; Vivaldi, P | 1 |
Kojima, M; Kusama, K; Sakashita, H; Shigematsu, H; Tanaka, A | 1 |
Asahi, A; Harabuchi, Y; Ishida, Y; Kanai, N; Kishibe, K; Kobayashi, Y; Moriai, S; Wada, T | 1 |
Izutsu, K; Kurokawa, M; Nagai, S; Watanabe, T | 1 |
Habermann, TM; Kumar, N; Luthra, HS; Sandroni, P; Steensma, DP | 1 |
Satoh, T; Shimura, C; Takayama, K; Yokozeki, H | 1 |
Ando, K; Bunno, M; Hatanaka, K; Irie, S; Kojima, M; Nakamine, H; Nakamura, N; Uekusa, T | 1 |
Imaizumi, K; Komatsuda, A; Satoh, K; Sawada, K; Wakui, H; Yajima, M; Yoshida, N | 1 |
Curry, JL; Diwan, AH; Duvic, M; Jones, DM; Prieto, VG; Vega, F | 1 |
ADACHI, S; ASADA, D; KATO, I; MATSUBARA, H; NAKAHATA, T; OKAMOTO, S; OSADA, K; TOKUMASU, M; UEMOTO, S; UMEDA, K; URYU, K; WATANABE, K | 1 |
Aozasa, K; Hatachi, S; Kunitomi, A; Yagita, M | 1 |
Kikuchi, K; Kojima, M; Kusama, K; Miyazaki, Y; Sakashita, H; Shigematu, H; Tanaka, A | 1 |
Hirata, K; Imamura, M; Kuramoto, R; Oridate, N; Suzuki, S; Takei, T; Tamaki, N; Yamada, Y | 1 |
El-Shaboury, H; Fasler, JJ; Guirguis, R; Joannides, AJ; Rajagopal, V | 1 |
Amano, K; Itoyama, S; Kameda, H; Kizaki, M; Mori, S; Nagasawa, H; Nemoto, T; Sagawa, M; Takeuchi, T; Tamaru, J; Tokuhira, M; Tomikawa, T; Watanabe, R | 1 |
Ye, BD | 1 |
Abe, H; Sato, Y | 1 |
Hashizume, H; Kawamura, T; Suda, T; Takigawa, M; Tokura, Y; Uchiyama, I | 1 |
Ardura, MI; Harker-Murray, P; Johnson-Welch, SF; Pokala, H; Seikaly, M; Twombley, K; Weinberg, A | 1 |
Fujimoto, M; Haga, H; Huang, CL; Kobashi, Y; Koyanagi, I; Sakashita, H; Yuba, Y | 1 |
Bouscary, D; Dreyfus, F; Kahan, A; Kelaïdi, C; Lecoq-Lafon, C; Pham, XV; Tulliez, M | 1 |
Gordon, KB; McClure, SL; Valentine, J | 1 |
Caballero, D; Chopra, R; Craddock, C; García-Conde, J; Goldstone, AH; Hunter, A; Kottaridis, PD; Leon, A; Linch, DC; Mackinnon, S; Martino, R; Milligan, DW; Parker, A; Pérez-Simón, JA; San Miguel, JF; Schey, S; Sierra, J; Sureda, A; Urbano-Ispizua, A; Yong, K | 1 |
Brière, J; Dardenne, S; Detry, R; Emile, FJ; Fabiani, B; Gaulard, P; Guiot, Y; Michaux, L; Theate, I | 1 |
Berkow, RL; Hilliard, LM; Watts, RG | 1 |
Rocca, PV; Slease, RB; Vincent, S | 1 |
Bucuvalas, JC; Greiner, TC; Gross, TG; Hinrich, SH; Kaufman, SS; Langnas, AN; Lynch, JC; McDonald, RA; Park, JR; Ryckman, FC; Shaw, BW; Sudan, DL | 1 |
Heslop, HE | 1 |
Goto, T; Ito, R; Kawakami, K; Watanabe, Y | 1 |
Bradstock, KF; Gottlieb, D; Grigg, A; Hertzberg, M; Hoyt, R; Huang, G; Roberts, A; Szer, J | 1 |
Caggiari, L; De Re, V; De Vita, S; Fabris, M; Ferraccioli, G; Franzolini, N; Gasparotto, D; Marzotto, A; Quartuccio, L; Scott, CA | 1 |
Hirabayashi, K; Igarashi, S; Itoh, H; Kashiwabara, K; Kojima, M; Masawa, N; Murayama, K; Nakamura, S; Ogura, H; Saitoh, R; Takimoto, J; Tamaki, Y | 1 |
Aozasa, K; Hongyo, T; Hoshida, Y; Miyazato, H; Sasaki, T; Tomita, Y; Xu, JX | 1 |
Lade, S; McCormack, C; Prince, HM; Rodrigues, M; Westerman, D | 1 |
Aozasa, K; Fujita, S; Hoshida, Y; Iizuka, A; Ikeda, J; Nakamichi, I; Nakatsuka, S; Takeuchi, T; Tamaru, J; Tomita, Y; Xu, JX | 1 |
Adler, DJ; Clarke, LE; Elenitsas, R; Junkins-Hopkins, J; Seykora, JT | 1 |
Iizuka, A; Itoyama, S; Kameda, H; Okuyama, A; Takeuchi, T; Tamaru, J | 1 |
Chen, J; Li, JP; Zhang, T; Zhong, J; Zhu, KE | 1 |
Aiba, M; Kawauchi, K; Kimura, A; Ogasawara, T; Ohtuka, K; Yasuyama, M | 1 |
Blanche, S; de Saint Basile, G; Fischer, A; Mahlaoui, N; Neven, B; Ouachée-Chardin, M; Picard, C | 1 |
Cane, P; Gaffney, K; Jois, RN; Nicholson, AG; Wotherspoon, AC | 1 |
Abdallah-Lotf, M; de Muret, A; Machet, L; Machet, MC; Maruani, A; Wierzbicka, E | 1 |
Komatsuda, A; Nimura, T; Sawada, K; Wakui, H | 1 |
Chiefa, A; Curci, P; Delia, M; Liso, V; Rinaldi, E; Rizzi, R; Specchia, G | 1 |
Case, DC | 1 |
Arseniev, L; Bähre, O; Battmer, K; Berenson, RJ; Casper, J; Diedrich, H; Jacobs, R; Kadar, JG; Kühl, J; Link, H; Poliwoda, H; Schubert, J | 1 |
Carr, TJ; Costanzo, MR; Fisher, RI; Mullen, GM; Swinnen, LJ | 1 |
Cochand-Priollet, B; D'Agay, MF; D'Anglejan, G; Dombret, H; Kuntz, D; Lioté, F; Numéric, P; Pertuiset, E | 1 |
Hanasono, MM; Kamel, OW; van de Rijn, M; Warnke, RA | 1 |
Newkirk, MM; Shiroky, JB | 1 |
Kadin, ME; Sajjadian, A; Vonderheid, EC | 1 |
Cooper, DL; Crouch, J; Howe, G; Lacy, J; Murren, J; Salloum, E; Schultz, M; Tallini, G | 1 |
Banks, PM; Craig, FE; Gulley, ML; Myerson, GE; Sears, DL; Thomason, RW | 1 |
Bacigalupo, A; Brinch, L; Cook, G; Domingo-Albos, A; Finke, J; Garcia-Conde, J; Gratwohl, A; Labopin, M; Lambertenghi-Deliliers, G; Lange, A; Laporte, JP; Majolino, I; Rozman, C; Schmitz, N | 1 |
Colby, TV; Jaffe, ES; Kamel, OW; Kingma, DW; van de Rijn, M; Weiss, LM | 1 |
Kamel, OW; van de Rijn, M | 1 |
Bargay, J; Brunet, S; Caballero, D; de la Rubia, J; de la Serna, J; Domingo-Albós, A; Espigado, I; Figuera, A; García Conde, J; Hernández, F; Mataix, R; Moraleda, J; Ojeda, E; Pérez-Oteiza, J; Petit, J; Rozman, C; Sierra, J; Solano, C; Torrabadella, M; Urbano-Ispizua, A; Vivancos, P | 1 |
Bleyer, WA | 1 |
Berger, F; Blanc, M; Chevrel, G; Felman, C; Jeanneret, J; Miossec, P; Tebib, J | 1 |
Lindsley, HB; Moseley, AC; Skikne, BS; Tawfik, O | 1 |
Byrne, JL; Carter, GI; Cull, GM; Hale, G; Haynes, AP; Miflin, G; Rebello, P; Russell, NH; Waldmann, H | 1 |
LeBoit, PE | 1 |
Balbir-Gurman, A; Braun-Moscovici, Y; Nahir, AM; Schapira, D | 1 |
Boulanger, E; Clauvel, JP; Le Deist, F; Legall, M; Meignin, V; Oksenhendler, E; Picard, C; Rieux-Laucat, F; Sigaux, F | 1 |
Alvillar, RE; O'Grady, L; Robbins, D | 1 |
Frost, A; Haegert, DG; Neville, C; Newkirk, MM; Shiroky, JB; Skelton, JD | 1 |
Bäckman, L; Lönnqvist, B; Ringdén, O; Tollemar, J | 1 |
29 review(s) available for methotrexate and Duncan Disease
Article | Year |
---|---|
New Evidence of Significant Association between EBV Presence and Lymphoproliferative Disorders Susceptibility in Patients with Rheumatoid Arthritis: A Systematic Review with Meta-Analysis.
Topics: Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Databases, Factual; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Lymphoma; Lymphoproliferative Disorders; Methotrexate; Prevalence | 2022 |
Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature.
Topics: Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 2022 |
Primary central nervous system other iatrogenic immunodeficiency-associated lymphoproliferative disorders presenting as extraosseous plasmacytoma with a progressive clinical course: A case report and literature review.
Topics: Aged; Arthritis, Rheumatoid; Central Nervous System; Disease Progression; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Iatrogenic Disease; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Neoplasm Recurrence, Local; Plasmacytoma | 2023 |
Methotrexate-associated lymphoproliferative disorder presenting as an ulcer with tendon exposure on the dorsum of the hand: a case report and literature review.
Topics: Aged; Arthritis, Rheumatoid; Female; Hand; Humans; Infant; Lymphoproliferative Disorders; Methotrexate; Ulcer | 2023 |
Skin-Limited, Methotrexate-Associated Epstein-Barr Virus-Positive Mucocutaneous Ulcer-A Mimicker of High-Grade Lymphoma. A Report of 4 Cases and Review of the Literature.
Topics: Epstein-Barr Virus Infections; Herpesvirus 4, Human; HIV Infections; Humans; Iatrogenic Disease; Immunologic Deficiency Syndromes; Lymphoma, B-Cell; Lymphoproliferative Disorders; Methotrexate; Precancerous Conditions; Ulcer | 2023 |
Central Nervous System Lymphoproliferative Disorder Secondary to Methotrexate: A Systematic Literature Review and Case Illustration.
Topics: Arthritis, Rheumatoid; Central Nervous System; Central Nervous System Diseases; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Methotrexate | 2023 |
Immune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Lymphoproliferative Disorders; Methotrexate | 2019 |
Rare Oral Presentation of a Mycophenolate Mofetil-Related Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorder (MMF-OIA-LPD) Lesion: A Case Report and Literature Review.
Topics: Aged; Arthritis, Rheumatoid; Humans; Iatrogenic Disease; Lymphoproliferative Disorders; Male; Methotrexate; Mycophenolic Acid | 2021 |
Primary hepatic lymphoma as other iatrogenic immunodeficiency-related lymphoproliferative disorders: a case report and review of the literature.
Topics: Aged; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Iatrogenic Disease; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Polymyositis | 2021 |
Clinical features and treatment strategies for post-transplant and iatrogenic immunodeficiency-associated lymphoproliferative disorders.
Topics: Animals; Disease Management; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Iatrogenic Disease; Immunity; Immunosuppressive Agents; Lymphoproliferative Disorders; Methotrexate; Organ Transplantation | 2021 |
Epstein-Barr virus-related lymphoma in rheumatoid arthritis: implications for long-term usage of immunosuppressive drugs and review of the literature.
Topics: Abatacept; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate | 2022 |
Methotrexate-Related Lymphoproliferative Disorder in Patients With Osteonecrosis of the Jaw: A 3-Case Report and Literature Review.
Topics: Aged; Arthritis, Rheumatoid; Biopsy; Debridement; Female; Humans; Immunohistochemistry; Lymphoproliferative Disorders; Male; Mandibular Diseases; Maxillary Diseases; Methotrexate; Osteonecrosis; Risk Factors | 2018 |
Methotrexate-associated lymphoproliferative disorder.
Topics: Age Factors; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Herpesvirus 4, Human; Humans; Immunity, Cellular; Lymphoproliferative Disorders; Male; Methotrexate; Prognosis; Risk Factors | 2017 |
Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: A review of the literature and current perspective.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Lymphoproliferative Disorders; Methotrexate | 2018 |
Oral Methotrexate-related Lymphoproliferative Disease Presenting with Severe Osteonecrosis of the Jaw: A Case Report and Literature Review.
Topics: Aged, 80 and over; Antirheumatic Agents; Female; Humans; Jaw; Lymphoproliferative Disorders; Methotrexate; Osteonecrosis; Severity of Illness Index | 2018 |
Endobronchial Manifestation of Methotrexate-induced Lymphoproliferative Disorder.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Bronchial Diseases; Bronchoscopy; Female; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Tomography, X-Ray Computed | 2019 |
Hepatic methotrexate-associated lymphoproliferative disorders identified by multiple liver tumors: a case report and review of the literature.
Topics: Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Humans; Lymphoproliferative Disorders; Male; Methotrexate | 2019 |
Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders with a T- or NK-cell phenotype.
Topics: Animals; Humans; Iatrogenic Disease; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Inflammatory Bowel Diseases; Lymphoproliferative Disorders; Methotrexate; Natural Killer T-Cells; T-Lymphocytes | 2019 |
Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders.
Topics: Animals; Arthritis, Rheumatoid; Disease Management; Humans; Iatrogenic Disease; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Lymphoproliferative Disorders; Methotrexate | 2019 |
Burkitt-like post-transplant lymphoproliferative disorder (PTLD) presenting with breast mass in a renal transplant recipient: a report of a rare case.
Topics: Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Immunophenotyping; Kidney Transplantation; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Postoperative Complications; Remission Induction; Vincristine | 2014 |
Methotrexate-associated lymphoproliferative disorders of the tongue developing in patients with rheumatoid arthritis: a report of 2 cases and a review.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Female; Humans; Lymphoproliferative Disorders; Methotrexate; Tongue Diseases | 2015 |
[Rheumatoid arthritis and malignancy].
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Colorectal Neoplasms; Female; Humans; Lung Neoplasms; Lymphoma; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Risk Factors | 2016 |
EBV-induced lymphoproliferative disorders in rheumatic patients: A systematic review of the literature.
Topics: Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Methotrexate; Rheumatic Diseases; RNA, Viral | 2018 |
[Inflammatory bowel disease and lymphoproliferative disorders].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Lymphoproliferative Disorders; Methotrexate; Risk Factors | 2011 |
Comparative tolerability of systemic treatments for plaque-type psoriasis.
Topics: Acitretin; Cyclosporine; Dermatologic Agents; Drug Combinations; Eye Diseases; Humans; Keratolytic Agents; Liver Cirrhosis; Lymphoproliferative Disorders; Methotrexate; Nausea; Pancytopenia; Pneumonia; Pruritus; Psoriasis; PUVA Therapy; Skin Neoplasms | 2002 |
Spontaneous remission of "methotrexate-associated lymphoproliferative disorders" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Autoimmune Diseases; Epstein-Barr Virus Infections; Female; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Pulse Therapy, Drug; Remission, Spontaneous; Time Factors | 2009 |
Immunosuppression-associated lymphoproliferative disorders in rheumatic patients.
Topics: Adult; Aged; Aged, 80 and over; B-Lymphocytes; Female; Follow-Up Studies; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppression Therapy; Lymphoma; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Rheumatic Diseases; Risk; Sjogren's Syndrome; Tumor Virus Infections | 1995 |
Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged | 1996 |
Reversible methotrexate associated lymphoproliferative disease evolving into Hodgkin's disease.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Disease Progression; Female; Herpesvirus 4, Human; Hodgkin Disease; Humans; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Tomography, X-Ray Computed; Virus Activation | 2000 |
3 trial(s) available for methotrexate and Duncan Disease
Article | Year |
---|---|
Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Confidence Intervals; Cyclophosphamide; Dose-Response Relationship, Drug; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Herpesvirus 4, Human; Humans; Infant; Lymphoproliferative Disorders; Male; Methotrexate; Organ Transplantation; Prednisone; Probability; Prospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome | 2005 |
Combined transplantation of allogeneic bone marrow and CD34+ blood cells.
Topics: Adult; Antigens, CD; Antigens, CD34; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Whole-Body Irradiation | 1995 |
An increased risk of relapse in cyclosporin-treated compared with methotrexate-treated patients: long-term follow-up of a randomized trial.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cataract; Child; Child, Preschool; Clinical Trials as Topic; Cyclosporins; Cytomegalovirus Infections; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Humans; Infant; Kidney; Liver; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Random Allocation | 1988 |
196 other study(ies) available for methotrexate and Duncan Disease
Article | Year |
---|---|
[A Case of Malignant Thyroid Lymphoma That Was Difficult to Differentiate from Methotrexate-Associated Lymphoproliferative Disorders(MTX-LPD)].
Topics: Antirheumatic Agents; Female; Humans; Lymphoma; Lymphoproliferative Disorders; Methotrexate; Neoplasm Recurrence, Local; Thyroid Neoplasms | 2021 |
Angioimmunoblastic T-cell Lymphoma Presenting as a Methotrexate-associated Lymphoproliferative Disorder with Extreme Peripheral Blood Plasmacytosis.
Topics: Aged; Humans; Immunoblastic Lymphadenopathy; Lymphadenopathy; Lymphoma, T-Cell; Lymphoproliferative Disorders; Male; Methotrexate | 2022 |
Pneumonia and Meningoencephalitis Due to Varicella-zoster Virus Reinfection and Epstein-Barr Virus Reactivation in a Patient with Rheumatoid Arthritis.
Topics: Aged; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 3, Human; Herpesvirus 4, Human; Humans; Liver Neoplasms; Lymphoproliferative Disorders; Meningoencephalitis; Methotrexate; Pneumonia; Reinfection; Valacyclovir | 2022 |
Magnetic resonance imaging of methotrexate-related lymphoproliferative disorder with a chief complaint of oral symptoms.
Topics: Arthritis, Rheumatoid; Diffusion Magnetic Resonance Imaging; Humans; Lymphoproliferative Disorders; Magnetic Resonance Imaging; Methotrexate | 2023 |
Diffuse Large B-cell Lymphoma with Adrenal Involvement Presenting as Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorders: Sustained Remission with Methotrexate Termination Alone in Two Cases.
Topics: Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Iatrogenic Disease; Immunologic Deficiency Syndromes; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate; Neoplasm Recurrence, Local | 2023 |
Extremely delayed-onset post-transplant lymphoproliferative disorder in a renal transplant patient.
Topics: Adult; Epstein-Barr Virus Infections; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoproliferative Disorders; Methotrexate; Rituximab | 2022 |
FDG-PET/CT imaging parameters for predicting spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Methotrexate; Positron Emission Tomography Computed Tomography | 2022 |
Unusual manifestation of methotrexate-associated lymphoproliferative disorder as a palatal mass.
Topics: Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Methotrexate; Palate | 2022 |
Response to Dr Urata's Letter to the Editor of Modern Rheumatology regarding a study of "Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders".
Topics: Arthritis, Rheumatoid; Humans; Lymphoproliferative Disorders; Methotrexate; Rheumatology | 2023 |
Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: A retrospective, multi-center descriptive study: Comment on the article by Nakano K et al.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Lymphoproliferative Disorders; Methotrexate; Retrospective Studies; Rheumatology | 2023 |
Primary hepatic methotrexate-associated lymphoproliferative disorder associated with Epstein-Barr virus reactivation and accompanied by spontaneous necrosis: A case report.
Topics: Antigens, CD; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Liver; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Necrosis | 2022 |
Clinicopathological findings, prognosis, and Epstein-Barr virus infection in rheumatoid arthritis patients with other iatrogenic immunodeficiency-associated T- and NK-cell lymphoproliferative disorders.
Topics: Arthritis, Rheumatoid; Disease Progression; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Iatrogenic Disease; Killer Cells, Natural; Lymphoproliferative Disorders; Methotrexate; Prognosis; Tumor Suppressor Protein p53 | 2022 |
[Methotrexate-related lymphoproliferative disease showing different histological findings at recurrence].
Topics: Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 2023 |
Epstein-Barr virus-positive CD30+ B-cell lymphoproliferative disease with histologic features resembling grade III lymphomatoid granulomatosis induced by methotrexate.
Topics: Arthritis, Rheumatoid; B-Lymphocytes; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Ki-1 Antigen; Lymphomatoid Granulomatosis; Lymphoproliferative Disorders; Methotrexate | 2023 |
Hepatic Superscan in Methotrexate-Associated Lymphoproliferative Disorder.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Liver; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Positron Emission Tomography Computed Tomography | 2023 |
Macrophage activation syndrome triggered by methotrexate-related lymphoproliferative disease in a patient with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Female; Humans; Lymphoproliferative Disorders; Macrophage Activation Syndrome; Methotrexate; Middle Aged | 2023 |
Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Lymphoproliferative Disorders; Methotrexate; Retrospective Studies; Tacrolimus | 2023 |
A case of classic Hodgkin lymphoma arising after remission of methotrexate-associated follicular lymphoma.
Topics: Aged; Hodgkin Disease; Humans; Lymphoma, Follicular; Lymphoproliferative Disorders; Male; Methotrexate; Neoplasm Recurrence, Local; Rituximab | 2023 |
Methotrexate-associated lymphoproliferative disorder in the thyroid gland of a patient with chronic thyroiditis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Lymphoproliferative Disorders; Methotrexate; Thyroid Gland | 2023 |
[Methotrexate-associated lymphoproliferative disorders: clinical aspects].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Incidence; Lymphoproliferative Disorders; Methotrexate; Prognosis | 2019 |
EBV-positive mucocutaneous ulcer in a patient with systemic lupus erythematosus.
Topics: Azathioprine; Conservative Treatment; Deprescriptions; Epstein-Barr Virus Infections; Facial Dermatoses; Female; Forehead; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Skin Ulcer | 2020 |
Immunohistochemical Assessment of the Diagnostic Utility of PD-L1 (Clone SP142) for Methotrexate-Associated Lymphoproliferative Disorders With an Emphasis of Neoplastic PD-L1 (Clone SP142)-Positive Classic Hodgkin Lymphoma Type.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; B7-H1 Antigen; Female; Hodgkin Disease; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged | 2020 |
Distinct decrease in peripheral lymphocytes in EBER-positive cases of MTX-LPD.
Topics: Aged; Arthritis, Rheumatoid; Female; Humans; Immunosuppressive Agents; Japan; Lymphocyte Count; Lymphocytes; Lymphoproliferative Disorders; Male; Methotrexate; Outcome Assessment, Health Care; Recurrence; Withholding Treatment | 2021 |
A case of esophageal cancer complicated with methotrexate-related lymphoproliferative disorder.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Esophageal Neoplasms; Female; Humans; Lymphoproliferative Disorders; Methotrexate; Tomography, X-Ray Computed | 2020 |
Clinical aspects in patients with rheumatoid arthritis complicated with lymphoproliferative disorders without regression after methotrexate withdrawal and treatment for arthritis after regression of lymphoproliferative disorders.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Incidence; Japan; Lymphocyte Count; Lymphocytes; Lymphoproliferative Disorders; Male; Methotrexate; Recurrence; Risk Assessment; Withholding Treatment | 2021 |
Methotrexate-associated Lymphoproliferative Disorder of the Small Intestine.
Topics: Arthritis, Rheumatoid; Humans; Intestine, Small; Lymphoproliferative Disorders; Methotrexate | 2021 |
Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Composite Lymphoma; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Female; Humans; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate; Pharynx; Prednisone; Rituximab; Ulcer; Vincristine | 2020 |
The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disorders.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Lymphocyte Count; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Prognosis; Retrospective Studies | 2020 |
Methotrexate-associated Lymphoproliferative Disorder in the Liver Resembling Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Diagnosis, Differential; Female; Humans; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate | 2020 |
Methotrexate-Associated Lymphoproliferative Disorders Mimicking Granulomatosis With Polyangiitis: A Radiological Diagnostic Challenge.
Topics: Arthritis, Rheumatoid; Female; Granulomatosis with Polyangiitis; Humans; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Tomography, X-Ray Computed | 2022 |
Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: a retrospective, multi-center descriptive study.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Lymphoproliferative Disorders; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies | 2022 |
Nodal EBV-positive polymorphic B cell lymphoproliferative disorder with plasma cell differentiation: clinicopathological analysis of five cases.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; B-Lymphocytes; Biomarkers, Tumor; Cell Differentiation; Diagnosis, Differential; Epstein-Barr Virus Infections; Female; Genes, Immunoglobulin Heavy Chain; Genes, T-Cell Receptor gamma; Herpesvirus 4, Human; Host-Pathogen Interactions; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Plasma Cells; Predictive Value of Tests; Risk Factors | 2021 |
Methotrexate-associated lymphoproliferative disorder with histopathological features of histiocytic necrotizing lymphadenitis.
Topics: Aged, 80 and over; Arthritis, Rheumatoid; Biopsy; Female; Herpesvirus 4, Human; Histiocytic Necrotizing Lymphadenitis; Humans; Lymph Nodes; Lymphoproliferative Disorders; Methotrexate | 2021 |
Overall survival and post-spontaneous regression relapse-free survival of patients with lymphoproliferative disorders associated with rheumatoid arthritis: a multi-center retrospective cohort study.
Topics: Aged; Arthritis, Rheumatoid; Hodgkin Disease; Humans; Longitudinal Studies; Lymphoproliferative Disorders; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies | 2022 |
Cessation of methotrexate and a small intestinal resection provide a good clinical course for a patient with a jejunum perforation induced by a methotrexate-associated lymphoproliferative disorder: a case report.
Topics: Aged, 80 and over; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Intestinal Perforation; Jejunum; Lymphoproliferative Disorders; Methotrexate; Neoplasm Recurrence, Local; Prognosis | 2021 |
Association of methotrexate use and lymphoproliferative disorder in patients with rheumatoid arthritis: Results from a Japanese multi-institutional retrospective study.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Japan; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Retrospective Studies | 2022 |
Rheumatoid arthritis relapse in patients with other iatrogenic immunodeficiency-associated lymphoproliferative disorders and its treatment.
Topics: Arthritis, Rheumatoid; Humans; Iatrogenic Disease; Lymphoproliferative Disorders; Methotrexate; Recurrence; Retrospective Studies | 2021 |
Characteristics of rheumatoid arthritis with immunodeficiency-associated lymphoproliferative disorders to regress spontaneously by the withdrawal of methotrexate and their clinical course: A retrospective, multicenter, case-control study.
Topics: Arthritis, Rheumatoid; Case-Control Studies; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Methotrexate; Retrospective Studies | 2022 |
Disappearance of bilateral adrenal tumours: immunodeficiency-associated lymphoproliferative disorder in a patient with rheumatoid arthritis.
Topics: Adrenal Gland Neoplasms; Aged; Arthritis, Rheumatoid; Deprescriptions; Drug Therapy, Combination; Female; Humans; Iatrogenic Disease; Immunosuppressive Agents; Infliximab; Lymphoma; Lymphoproliferative Disorders; Methotrexate; Neoplasm Regression, Spontaneous; Tumor Necrosis Factor Inhibitors | 2021 |
[EBV-positive MTX-associated lymphoproliferative disorder and Ig M myeloma in rheumatoid arthritis].
Topics: Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Lymph Nodes; Lymphoproliferative Disorders; Methotrexate; Paraproteinemias | 2021 |
Systemic EBV-Positive Methotrexate-Related Lymphoproliferative Disorder Associated With Skin Lesion Resembling EBV-Positive Mucocutaneous Ulcer: A Report of Two Cases.
Topics: Aged; Arthritis, Rheumatoid; Diagnosis, Differential; Drug Eruptions; Epstein-Barr Virus Infections; Female; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Methotrexate; Skin Ulcer | 2021 |
Primary cutaneous methotrexate-associated B-cell lymphoproliferative disorders other than EBV-positive mucocutaneous ulcer: clinical, pathological, and immunophenotypic features.
Topics: Aged; Aged, 80 and over; Cohort Studies; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunophenotyping; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Remission Induction; Ulcer | 2021 |
Clinicopathological characteristics of lymphoproliferative disorders in 232 patients with rheumatoid arthritis in Japan: A retrospective, multicenter, descriptive study.
Topics: Aged; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Japan; Lymphadenopathy; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Retrospective Studies; Ulcer | 2022 |
Methotrexate-associated lymphoproliferative disorder with an osteolytic vertebral lesion in an elderly patient with rheumatoid arthritis: A case report.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Thoracic Vertebrae | 2021 |
Methotrexate-associated lymphoproliferative disorder of the thoracic spine in a patient with rheumatoid arthritis receiving methotrexate: a case report.
Topics: Arthritis, Rheumatoid; Female; Humans; Lumbar Vertebrae; Lymphoma; Lymphoproliferative Disorders; Methotrexate; Middle Aged | 2021 |
[Early onset of methotrexate-associated lymphoproliferative disorder mimicking Hodgkin's lymphoma].
Topics: Arthritis, Rheumatoid; Female; Hodgkin Disease; Humans; Lymphoproliferative Disorders; Methotrexate; Middle Aged | 2022 |
Outcomes of methotrexate-associated lymphoproliferative disorders in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Arthritis, Rheumatoid; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Humans; Janus Kinases; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Prednisone; Progression-Free Survival; Proportional Hazards Models; Rituximab; Treatment Outcome; Tumor Necrosis Factor-alpha; Vinblastine; Vincristine | 2021 |
Development of Intravascular Large B-cell Lymphoma during Methotrexate Treatment for Rheumatoid Arthritis.
Topics: Arthritis, Rheumatoid; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate; Middle Aged | 2022 |
Small intestinal follicular lymphoma induced by methotrexate: a case report.
Topics: Aged; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Jejunum; Lymphoma, Follicular; Lymphoproliferative Disorders; Methotrexate; Neoplasm Recurrence, Local | 2021 |
[Oral Mucosal Diffuse Large B-cell Lymphoma Caused by Long-term Oral Methotrexate:Report of One Case].
Topics: Arthritis, Rheumatoid; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate | 2021 |
Successful treatment of CNS involvement in a patient with widely disseminated PTLD through the addition of intrathecal methotrexate to standard therapy.
Topics: Central Nervous System Neoplasms; Child; Humans; Injections, Spinal; Lymphoproliferative Disorders; Methotrexate; Organ Transplantation | 2021 |
Association of MTHFR and ABCB1 polymorphisms with MTX-induced mucositis in Chinese paediatric patients with acute lymphoblastic leukaemia, lymphoma or osteosarcoma-A retrospective cohort study.
Topics: Adolescent; Asian People; ATP Binding Cassette Transporter, Subfamily B; Child; Child, Preschool; China; Female; Genotype; Humans; Infant; Lymphoma; Lymphoproliferative Disorders; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Mucositis; Osteosarcoma; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies | 2021 |
Involvement of Epstein-Barr virus in the development and spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Methotrexate | 2022 |
Iguratimod triggers the relapse of methotrexate-associated lymphoproliferative disorder.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Chromones; Female; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Methotrexate; Recurrence; Sulfonamides | 2021 |
The aggressive clinical courses of Hodgkin lymphoma primarily diagnosed as methotrexate-induced non-specific lymphoproliferative disorder in patients with rheumatoid arthritis.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Arthritis, Rheumatoid; Female; Hodgkin Disease; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Prednisolone; Recurrence; Remission Induction | 2017 |
Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: Comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types.
Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Disease Progression; Female; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged | 2017 |
[A Case of Bilateral Adrenal Incidentaloma in which MTX-Related Lymphoproliferative Disease Could Be Diagnosed by Computed Tomography-Guided Biopsy and MTX Administration History].
Topics: Adrenal Gland Neoplasms; Aged; Humans; Image-Guided Biopsy; Incidental Findings; Lymphoproliferative Disorders; Male; Methotrexate; Tomography, X-Ray Computed | 2017 |
Clinical characteristics of methotrexate-associated lymphoproliferative disorders: relationship between absolute lymphocyte count recovery and spontaneous regression.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Cross-Sectional Studies; Female; Humans; Lymphocyte Count; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Remission Induction; Remission, Spontaneous; Retrospective Studies; Symptom Assessment | 2017 |
Methotrexate-associated lymphoproliferative disorder in a patient with neuromyelitis optica spectrum disorder: An implication for pathogenesis mediated by Epstein-Barr virus.
Topics: Adult; Epstein-Barr Virus Infections; Female; Humans; Lymphoproliferative Disorders; Methotrexate; Neuromyelitis Optica | 2017 |
Clinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Prognosis; Remission Induction; Survival Rate | 2018 |
Orbital T-cell lymphoma versus lupus panniculitits: a T-cell-mediated spectrum of orbital lymphoproliferative disease.
Topics: Administration, Oral; Adult; Diagnosis, Differential; Glucocorticoids; Humans; Immunosuppressive Agents; Lymphoma; Lymphoma, T-Cell; Lymphoproliferative Disorders; Magnetic Resonance Imaging; Male; Methotrexate; Orbital Neoplasms; Panniculitis, Lupus Erythematosus; Positron-Emission Tomography; Prednisone; Rare Diseases; Tomography, X-Ray Computed | 2018 |
Polymorphic lymphoproliferative disorders in patients with rheumatoid arthritis are associated with a better clinical outcome.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Female; Humans; Incidence; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Remission Induction | 2018 |
Methotrexate-associated lymphoproliferative disorder masquerading as multiple cerebral metastases.
Topics: Aged; Antirheumatic Agents; Brain Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Humans; Lymphoproliferative Disorders; Magnetic Resonance Imaging; Methotrexate; Vaginal Neoplasms | 2018 |
Methotrexate-associated lymphoproliferative disease with multiple pulmonary nodules in a patient with rheumatoid arthritis.
Topics: Administration, Intravenous; Aftercare; Antigens, CD20; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Glucocorticoids; Humans; Lymphoproliferative Disorders; Methotrexate; Methylprednisolone; Middle Aged; Multiple Pulmonary Nodules; Sjogren's Syndrome; Treatment Outcome | 2017 |
[A methotrexate-associated lympholiferative disorder patient with gastrointestinal perforation].
Topics: Aged; Arthritis, Rheumatoid; Female; Gastrointestinal Diseases; Humans; Lymphoproliferative Disorders; Methotrexate | 2017 |
Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder, Hodgkin Type, following Epstein-Barr Viral Hepatitis in a Patient with Rheumatoid Arthritis.
Topics: Arthritis, Rheumatoid; Biopsy; Epstein-Barr Virus Infections; Hepatitis, Viral, Human; Hodgkin Disease; Humans; Iatrogenic Disease; Infliximab; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged | 2018 |
Methotrexate-induced lymphoproliferative disorders: regression matters.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Lymphoproliferative Disorders; Methotrexate | 2018 |
Methotrexate-Associated B-Cell Lymphoproliferative Disease in a Patient With Cutaneous T-Cell Lymphoma.
Topics: Aged; Antimetabolites, Antineoplastic; B-Lymphocytes; Dermatitis; Facial Dermatoses; Humans; Lymphoma, T-Cell, Cutaneous; Lymphoproliferative Disorders; Male; Methotrexate; Scalp Dermatoses; Skin Neoplasms | 2018 |
Choledochoduodenal Fistula during Chemotherapy with Brentuximab Vedotin for Methotrexate-associated Lymphoproliferative Disorder.
Topics: Aged, 80 and over; Arthritis, Rheumatoid; Brentuximab Vedotin; Humans; Immunoconjugates; Jaundice, Obstructive; Lymphoproliferative Disorders; Male; Methotrexate | 2018 |
Restoration of Decreased T Helper 1 and CD8+ T Cell Subsets Is Associated With Regression of Lymphoproliferative Disorders Developed During Methotrexate Treatment.
Topics: Aged; Antigens, Viral; Antimetabolites, Antineoplastic; CD8-Positive T-Lymphocytes; Cell Proliferation; Female; Humans; Immunologic Memory; Interferon-gamma; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Remission Induction; Remission, Spontaneous; T-Lymphocyte Subsets; Th1 Cells; Withholding Treatment | 2018 |
The prognostic value of positron emission tomography/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disorders.
Topics: Aged; Arthritis, Rheumatoid; Female; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies | 2018 |
Japan College of Rheumatology guideline for the use of methotrexate in patients with rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Female; Humans; Japan; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Pneumonia, Pneumocystis; Risk Adjustment; Treatment Outcome | 2019 |
Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis: A Very Rare Case.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Chromones; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Neoplasm Recurrence, Local; Rare Diseases; Rituximab; Sulfonamides; Treatment Outcome | 2018 |
Methotrexate-associated lymphoproliferative disorder presenting as giant ulcers on the leg.
Topics: Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Leg Ulcer; Lymphoproliferative Disorders; Methotrexate | 2018 |
Methotrexate-associated lymphoproliferative disorder complicated by severe acute respiratory failure and ileal perforation:a case report.
Topics: Aged; Arthritis, Rheumatoid; Female; Humans; Ileal Diseases; Intestinal Perforation; Lymphoproliferative Disorders; Methotrexate; Respiratory Insufficiency | 2018 |
[Primary central nervous system methotrexate associated lymphoproliferative disorders in a patient with rheumatoid arthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Brain Neoplasms; Etanercept; Fatal Outcome; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate; Middle Aged | 2018 |
Methotrexate-related lymphoproliferative disorder of the lumbar spine origin presenting with severe low-back pain: case report.
Topics: Aged; Arthritis, Rheumatoid; Back Pain; Female; Humans; Lumbar Vertebrae; Lumbosacral Region; Lymphoproliferative Disorders; Methotrexate; Spinal Neoplasms | 2018 |
Spontaneous remission of methotrexate-associated lymphoproliferative disorder with Epstein-Barr virus type II latency.
Topics: Aged, 80 and over; Epstein-Barr Virus Infections; Female; Humans; Immunosuppressive Agents; Leg Ulcer; Lymphoproliferative Disorders; Methotrexate; Remission, Spontaneous | 2018 |
Methotrexate-associated Lymphoproliferative Disorder of the Stomach Presumed to Be Mucosa-associated Lymphoid Tissue Lymphoma.
Topics: Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Diagnosis, Differential; Female; Humans; In Situ Hybridization; Lymphoma, B-Cell, Marginal Zone; Lymphoproliferative Disorders; Methotrexate; Stomach; Stomach Neoplasms; Stomach Ulcer | 2018 |
Methotrexate-associated Lymphoproliferative Disorder with Diffuse Ground-Glass Opacities.
Topics: Female; Humans; Immunosuppressive Agents; Lung; Lymph Nodes; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Tomography, X-Ray Computed | 2019 |
Treatment of advanced stage methotrexate-associated lymphoproliferative disorders (MTX-LPDs) with methotrexate discontinuation.
Topics: Arthritis, Psoriatic; Autoimmune Diseases; Dermatomyositis; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Withholding Treatment | 2018 |
EBV-positive mucocutaneous ulcer arising in rheumatoid arthritis patients treated with methotrexate: Single center series of nine cases.
Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunohistochemistry; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Mouth Mucosa; Rituximab; Treatment Outcome; Ulcer | 2019 |
Methotrexate-associated Lymphoproliferative Disorder: A Rare Differential Diagnosis of Wheezes.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Female; Humans; Lymphoproliferative Disorders; Methotrexate; Respiratory Sounds | 2019 |
Methotrexate-associated lymphoproliferative disorder with multiple pulmonary nodules and bilateral cervical lymphadenopathy.
Topics: Aged; Arthritis, Rheumatoid; Female; Humans; Immunosuppressive Agents; Lymphadenopathy; Lymphoproliferative Disorders; Male; Methotrexate; Multiple Pulmonary Nodules; Neck; Tomography, X-Ray Computed | 2019 |
Cardiac Methotrexate-Induced Lymphoproliferative Disorder.
Topics: Aneurysm, Ruptured; Arthritis, Rheumatoid; Biopsy, Needle; Cardiac Surgical Procedures; Diagnosis, Differential; Female; Follow-Up Studies; Heart Aneurysm; Heart Neoplasms; Humans; Immunohistochemistry; Lymphoproliferative Disorders; Magnetic Resonance Imaging, Cine; Methotrexate; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Rare Diseases; Sinus of Valsalva; Treatment Outcome | 2019 |
Methotrexate-Associated Lymphoproliferative Disorder: A Rare Case of Large Liver Tumors.
Topics: Aged; Antirheumatic Agents; Female; Humans; Liver Neoplasms; Lymphoproliferative Disorders; Methotrexate; Tumor Burden | 2019 |
Clinicopathological features of clinical methotrexate-related lymphoproliferative disorders.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Disease Susceptibility; Female; Humans; Immunohistochemistry; Immunosuppressive Agents; In Situ Hybridization; Kaplan-Meier Estimate; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Tomography, X-Ray Computed | 2019 |
Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases.
Topics: Aged; Aged, 80 and over; Cell Proliferation; Female; Herpesvirus 4, Human; Humans; Immunoblastic Lymphadenopathy; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Phenotype; Prognosis; Retrospective Studies; T-Lymphocyte Subsets; T-Lymphocytes, Cytotoxic | 2019 |
Methotrexate-associated lymphoproliferative disorder in the stomach and duodenum: a case report.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclophosphamide; Doxorubicin; Duodenal Diseases; Endoscopy, Digestive System; Female; Humans; Lymphoproliferative Disorders; Methotrexate; Prednisone; Recurrence; Rituximab; Stomach Diseases; Vincristine; Withholding Treatment | 2019 |
Methotrexate-associated Lymphoproliferative Disorders in Patients With Rheumatoid Arthritis: Clinicopathologic Features and Prognostic Factors.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Disease Progression; Drug Administration Schedule; Female; Herpesvirus 4, Human; Humans; Immunocompromised Host; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Opportunistic Infections; Progression-Free Survival; Risk Assessment; Risk Factors; RNA, Viral; Time Factors | 2019 |
Methotrexate-induced iatrogenic immunodeficiency-associated lymphoproliferative disorder causing hypercalcaemia.
Topics: Dermatologic Agents; Diagnosis, Differential; Female; Humans; Hypercalcemia; Immunologic Deficiency Syndromes; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Psoriasis; Sjogren's Syndrome | 2019 |
[A Case of Small Bowel Perforation Caused by Malignant Lymphoma after Methotrexate Therapy for Rheumatoid Arthritis].
Topics: Aged; Arthritis, Rheumatoid; Female; Humans; Intestinal Perforation; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate; Positron Emission Tomography Computed Tomography | 2019 |
Rheumatoid Arthritis Complicated with Nasal Septum Perforation Due to Methotrexate-associated Lymphoproliferative Disorder.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Lymph Nodes; Lymphoproliferative Disorders; Methotrexate; Nasal Septal Perforation; Nasal Septum | 2019 |
Intracranial Methotrexate-Associated Lymphoproliferative Disorder in Rheumatoid Arthritis.
Topics: Aged; Arthritis, Rheumatoid; Biopsy; Female; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Methotrexate; Treatment Outcome | 2019 |
Gastric Perforation due to Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder during the Treatment of Rheumatoid Arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Female; Humans; Iatrogenic Disease; Lymphoproliferative Disorders; Methotrexate; Peptic Ulcer Perforation; Tacrolimus | 2019 |
Mature T/NK-cell lymphoproliferative disease and Epstein-Barr virus infection are more frequent in patients with rheumatoid arthritis treated with methotrexate.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Humans; Killer Cells, Natural; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Retrospective Studies | 2013 |
Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Arthritis, Rheumatoid; Disease Progression; Disease-Free Survival; Female; Herpesvirus 4, Human; Humans; Immunoglobulin Heavy Chains; Immunohistochemistry; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Regression Analysis; Treatment Outcome; Virus Activation | 2013 |
Posttransplant lymphoproliferative disorder in an 11-year-old immunosuppressed boy.
Topics: Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain; Child; Dacarbazine; Heart Transplantation; Humans; Hypesthesia; Immunosuppression Therapy; Lymphoproliferative Disorders; Magnetic Resonance Imaging; Male; Methotrexate; Muscle Weakness; Rituximab; Temozolomide | 2013 |
Primary central nervous system malignant lymphoma in a patient with rheumatoid arthritis receiving low-dose methotrexate treatment.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Central Nervous System Neoplasms; Female; Humans; Immunohistochemistry; Interleukin-2 Receptor alpha Subunit; Lymphoma; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Treatment Outcome | 2013 |
Fatal pulmonary lymphomatoid granulomatosis in a patient taking methotrexate for rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Epstein-Barr Virus Infections; Fatal Outcome; Female; Humans; Iatrogenic Disease; Immunophenotyping; Immunosuppressive Agents; Lung Neoplasms; Lymphohistiocytosis, Hemophagocytic; Lymphomatoid Granulomatosis; Lymphoproliferative Disorders; Mesenteric Ischemia; Methotrexate; Middle Aged; Pneumonia, Bacterial; Radiography; Respiratory Insufficiency | 2014 |
Large ulceration of the oropharynx induced by methotrexate-associated lymphoproliferative disorders.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Oral Ulcer; Oropharynx | 2013 |
[MTX associated lymphoproliferative disorder].
Topics: Arthritis, Rheumatoid; Humans; Lymphoproliferative Disorders; Methotrexate; Recurrence | 2013 |
Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Gingiva; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Methotrexate | 2013 |
A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Herpesvirus 4, Human; HLA Antigens; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Polymyositis; Prognosis; Retrospective Studies | 2014 |
CD8-positive T-cell lymphoproliferative disorder associated with Epstein-Barr virus-infected B-cells in a rheumatoid arthritis patient under methotrexate treatment.
Topics: Arthritis, Rheumatoid; B-Lymphocytes; CD8-Positive T-Lymphocytes; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Lymph Nodes; Lymphoproliferative Disorders; Methotrexate; Middle Aged | 2016 |
[A case of iatrogenic immunodeficiency-associated lymphoproliferative disease in a patient treated with methotrexate for rheumatoid arthritis for 9 consecutive years, which Showed natural remission after discontinuation of MTX therapy].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Immunologic Deficiency Syndromes; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Time Factors | 2013 |
[Case report; a case of methotrexate-associated lymphoproliferative disorders caused with multiple lung nodules].
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; DNA, Viral; Female; Herpesvirus 4, Human; Humans; Lung; Lymphoproliferative Disorders; Methotrexate; Radiography, Thoracic; Tomography, X-Ray Computed | 2013 |
Resolution of methotrexate-induced Epstein-Barr virus-associated mucocutaneous ulcer.
Topics: Aged; Epstein-Barr Virus Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Oral Ulcer | 2014 |
Clinical characteristics and incidence of methotrexate-related lymphoproliferative disorders of patients with rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Female; Humans; Incidence; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Retrospective Studies | 2014 |
Epstein-Barr virus-related MTX-LPD in rheumatoid arthritis patients exhibits a viral pattern of the CD64 and CD35 expression on neutrophils: three case reports.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Neutrophils; Receptors, Complement 3b; Receptors, IgG | 2015 |
Association of higher methotrexate dose with lymphoproliferative disease onset in rheumatoid arthritis patients.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Case-Control Studies; Female; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Risk Factors | 2014 |
Pulmonary and retroperitoneal lesions induced by methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Humans; Lung; Lymphoproliferative Disorders; Male; Methotrexate; Retroperitoneal Fibrosis; Tomography, X-Ray Computed | 2016 |
Methotrexate-associated lymphoproliferative disorder arising in the retromolar triangle and lung of a patient with rheumatoid arthritis.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Female; Humans; In Situ Hybridization; Lymphoproliferative Disorders; Methotrexate; Prednisone; Rituximab; Vincristine | 2014 |
Successful treatment of systemic and central nervous system post-transplant lymphoproliferative disorder without the use of high-dose methotrexate or radiation.
Topics: Bone Marrow; Central Nervous System; Child; Female; Heart Transplantation; Humans; Lymphoproliferative Disorders; Methotrexate | 2014 |
Therapy-related myeloid neoplasm in methotrexate-associated lymphoproliferative disease in a rheumatoid arthritis patient.
Topics: Arthritis, Rheumatoid; Bone Marrow; Fatal Outcome; Female; Humans; Immunohistochemistry; Immunosuppressive Agents; In Situ Hybridization, Fluorescence; Leukemia, Myeloid; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Neoplasms, Second Primary | 2014 |
Lymphoma Risk in Japanese Patients With Rheumatoid Arthritis: Comment on the Article by Kameda et al.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Lymphoproliferative Disorders; Male; Methotrexate | 2015 |
Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Disease Management; Female; Follow-Up Studies; Humans; Immunoglobulin G; Lymphocyte Count; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Neoplasm Regression, Spontaneous; Prognosis; Retrospective Studies; Watchful Waiting | 2015 |
[A case of methotrexate-associated lymphoproliferative disorder diagnosed by liver biopsy].
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Fatal Outcome; Female; Humans; Liver; Lymphoproliferative Disorders; Methotrexate | 2015 |
Primary cerebral lymphomatoid granulomatosis progressing to methotrexate-associated lymphoproliferative disease under immunosuppressive therapy.
Topics: Adult; Brain Neoplasms; Female; Humans; Immunosuppressive Agents; Lymphomatoid Granulomatosis; Lymphoproliferative Disorders; Methotrexate | 2015 |
Methotrexate-associated Lymphoproliferative Disease with Multiple Pulmonary Nodules in a Patient with Rheumatoid Arthritis.
Topics: Aged; Arthritis, Rheumatoid; Female; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Methotrexate; Multiple Pulmonary Nodules | 2015 |
Spontaneous Regression of Methotrexate-related Lymphoproliferative Disorder with T-cell Large Granular Lymphocytosis.
Topics: Aged; Arthritis, Rheumatoid; Female; Humans; Immunosuppressive Agents; Lymphocytosis; Lymphoproliferative Disorders; Methotrexate; Prognosis; Remission, Spontaneous; T-Lymphocytes | 2015 |
Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Asparaginase; Diagnosis, Differential; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Risk; Steroids | 2015 |
Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Human C1q Deficiency: The Karolinska Experience.
Topics: Adolescent; Adult; Child; Child, Preschool; Complement C1q; Cortisone; Cyclosporine; Fatal Outcome; Female; Gastrointestinal Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Heterozygote; Humans; Infant; Iraq; Lupus Erythematosus, Systemic; Lymphoproliferative Disorders; Male; Methotrexate; Postoperative Complications; Rituximab; Sweden; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2016 |
A case of rheumatoid arthritis with methotrexate related lymphoproliferative diseases of the knee.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Knee; Lymphoproliferative Disorders; Methotrexate; Middle Aged | 2018 |
Numb chin syndrome as initial manifestation of bisphosphonate-related osteomyelitis of the jaw and methotrexate-associated lymphoproliferative disorders: a rare case.
Topics: Chin; Diphosphonates; Humans; Hypesthesia; Jaw Diseases; Lymphoproliferative Disorders; Methotrexate; Osteomyelitis | 2016 |
Methotrexate-related lymphoproliferative disorder of the stomach in a patient with rheumatoid arthritis: a case of disease regression after methotrexate cessation.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate; Multimodal Imaging; Neoplasm Regression, Spontaneous; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2016 |
Endobronchial Involvement in Methotrexate-associated Lymphoproliferative Disease.
Topics: Aged; Antirheumatic Agents; Bronchial Diseases; Humans; Lymphoproliferative Disorders; Male; Methotrexate | 2016 |
Methotrexate-associated orbital lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Lymphoproliferative Disorders; Methotrexate; Orbital Diseases; Positron-Emission Tomography; Tomography, X-Ray Computed | 2016 |
Epstein-Barr virus-associated B-cell lymphoproliferative disorder in a patient with Sézary syndrome treated by methotrexate.
Topics: Aged; Antimetabolites, Antineoplastic; Fatal Outcome; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Sezary Syndrome; Skin Neoplasms | 2016 |
Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis.
Topics: Arthritis, Rheumatoid; Female; Humans; Japan; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Remission Induction | 2016 |
Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Topics: Adrenal Cortex Hormones; Age of Onset; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Carcinoma; Colitis, Ulcerative; Colorectal Neoplasms; Crohn Disease; Female; Follow-Up Studies; France; Humans; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Intestinal Neoplasms; Lymphoproliferative Disorders; Male; Mesalamine; Methotrexate; Middle Aged; Myeloproliferative Disorders; Neoplasms; Proportional Hazards Models; Protective Factors; Registries; Retrospective Studies; Risk Factors; Time Factors; Tumor Necrosis Factor-alpha | 2016 |
The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD).
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2016 |
A case of multiple hepatic lesions associated with methotrexate-associated lymphoproliferative disorder.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Follow-Up Studies; Humans; Liver; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Renal Insufficiency, Chronic | 2016 |
Sternoclavicular Joint Swelling in a Patient with Rheumatoid Arthritis.
Topics: Aged; Arthritis, Reactive; Arthritis, Rheumatoid; Biopsy, Needle; Edema; Female; Follow-Up Studies; Humans; Immunohistochemistry; Lymphoproliferative Disorders; Methotrexate; Rare Diseases; Recovery of Function; Severity of Illness Index; Sternoclavicular Joint; Ultrasonography, Doppler; Withholding Treatment | 2016 |
Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Factors; DNA, Viral; Female; Herpesvirus 4, Human; Humans; Japan; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Prognosis; Withholding Treatment | 2017 |
Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Case-Control Studies; CpG Islands; DNA Methylation; Epstein-Barr Virus Infections; Female; Genetic Markers; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Promoter Regions, Genetic; Treatment Outcome | 2017 |
Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional Therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azathioprine; Crohn Disease; Demyelinating Diseases; Drug Substitution; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hematologic Diseases; Humans; Immunosuppressive Agents; Infections; Infliximab; Infusions, Intravenous; Lymphoproliferative Disorders; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Mortality; Narcotics; Prednisone; Prospective Studies; Registries; Risk Factors; Sulfasalazine; Time Factors; Young Adult | 2017 |
Arthrorheumatism with methotrexate-associated lymphoproliferative disorder in the brain.
Topics: Aged; Arthritis, Rheumatoid; Brain; Female; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Treatment Outcome | 2016 |
Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Case-Control Studies; Female; Humans; Lymphocyte Count; Lymphopenia; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Retrospective Studies | 2017 |
Methotrexate-associated lymphoproliferative disorder arising in a patient with adult Still's disease.
Topics: Adult; Antirheumatic Agents; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Maxillary Diseases; Methotrexate; Still's Disease, Adult-Onset | 2008 |
[Three cases of methotrexate-associated lymphoproliferative disorder (MTX-LPD)].
Topics: Aged; Arthritis, Rheumatoid; Female; Humans; Lymphoproliferative Disorders; Methotrexate | 2008 |
Simultaneous appearance of methotrexate-associated lymphoproliferative disorder and tuberculous meningitis demonstrating the definitive role of immunosuppression.
Topics: Aged; Arthritis, Rheumatoid; Female; Humans; Immunosuppression Therapy; Lymphoproliferative Disorders; Methotrexate; Tuberculosis, Meningeal | 2009 |
Polyradiculopathy due to methotrexate-induced ebv-associated lymphoproliferative disorder.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Polyradiculopathy | 2008 |
Methotrexate-related lymphoproliferative disorder with extensive vascular involvement in a patient with rheumatoid arthritis.
Topics: Aged, 80 and over; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Methotrexate; Skin Diseases | 2009 |
Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Proliferation; Diagnosis, Differential; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell; Lymphoproliferative Disorders; Male; Methotrexate | 2010 |
Reversible methotrexate-associated lymphoproliferative disorder resembling advanced gastric cancer in a patient with rheumatoid arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Lymphoproliferative Disorders; Methotrexate; Stomach Neoplasms; Treatment Outcome | 2009 |
Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome.
Topics: Aged; Azathioprine; B-Lymphocytes; Epstein-Barr Virus Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Mycosis Fungoides; Prednisone; Sezary Syndrome; Skin Neoplasms | 2011 |
Acute renal failure after high-dose methotrexate therapy in a patient with ileostomy.
Topics: Acute Kidney Injury; Biliary Atresia; Burkitt Lymphoma; Child, Preschool; Drainage; Humans; Hypovolemia; Ileostomy; Intestinal Perforation; Liver Transplantation; Lymphoproliferative Disorders; Male; Methotrexate | 2009 |
CD8(+) T-cell lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis during methotrexate therapy.
Topics: Acyclovir; Aged; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; CD8-Positive T-Lymphocytes; Epstein-Barr Virus Infections; Female; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunophenotyping; Lymph Nodes; Lymphoproliferative Disorders; Meningoencephalitis; Methotrexate; Methylprednisolone | 2010 |
Methotrexate-related Epstein-Barr Virus (EBV)-associated lymphoproliferative disorder--so-called "Hodgkin-like lesion"--of the oral cavity in a patient with rheumatoid arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Methotrexate; Mouth; RNA, Viral | 2010 |
FDG PET/CT in a patient with spontaneous remission of methotrexate-associated lymphoproliferative disorders after interruption of methotrexate.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Positron-Emission Tomography; Remission, Spontaneous; Tomography, X-Ray Computed | 2011 |
Methotrexate-associated lymphoproliferative disorder presenting as disseminated malignancy.
Topics: Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Neoplasms, Unknown Primary; Pleural Effusion; Withholding Treatment | 2011 |
Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis.
Topics: Adult; Aged; Aged, 80 and over; Antigens, CD20; Antirheumatic Agents; Arthritis, Rheumatoid; Chromosome Aberrations; Epstein-Barr Virus Infections; Female; Flow Cytometry; Humans; Immunocompromised Host; Immunohistochemistry; Karyotype; Ki-1 Antigen; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Prognosis; Survival Analysis | 2012 |
[Case report; a case suspected that methotrexate-associated lymphoproliferative disorders was developed in the course of therapy of rheumatoid arthritis].
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Lymphoproliferative Disorders; Male; Methotrexate | 2011 |
Epstein-Barr virus-positive mucocutaneous ulcers as a manifestation of methotrexate-associated B-cell lymphoproliferative disorders.
Topics: Antiviral Agents; Epstein-Barr Virus Infections; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Oral Ulcer; Polymyositis | 2012 |
Intraventricular rituximab and systemic chemotherapy for treatment of central nervous system post-transplant lymphoproliferative disorder after kidney transplantation.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; B-Lymphocytes; Central Nervous System Diseases; Dexamethasone; Drug Therapy, Combination; Epstein-Barr Virus Infections; Fatal Outcome; Herpesvirus 4, Human; Humans; Immunologic Factors; Infusions, Intraventricular; Kidney Transplantation; Lymphoproliferative Disorders; Magnetic Resonance Imaging; Male; Methotrexate; Postoperative Complications; Prognosis; Rituximab; Seizures; Treatment Outcome | 2012 |
Coexistence of Epstein-Barr virus-associated lymphoproliferative disorder and marginal zone B-cell lymphoma of the thymus in a patient with rheumatoid arthritis treated with methotrexate.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cell Transformation, Neoplastic; Comorbidity; Epstein-Barr Virus Infections; Humans; Lymphocytes; Lymphoma, B-Cell, Marginal Zone; Lymphoproliferative Disorders; Male; Methotrexate; Plasma Cells; Thymectomy; Thymus Neoplasms | 2012 |
Long-term remission of an EBV-positive B cell lymphoproliferative disorder associated with rheumatoid arthritis under methotrexate with anti-CD20 monoclonal antibody (Rituximab) monotherapy.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Arthritis, Rheumatoid; B-Lymphocytes; Female; Herpesvirus 4, Human; Humans; Immunohistochemistry; Lymph Nodes; Lymphoproliferative Disorders; Methotrexate; Remission Induction; Rituximab | 2002 |
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Infections; Life Tables; Lymphoproliferative Disorders; Male; Melphalan; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Spain; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; United Kingdom; Vidarabine | 2002 |
Epstein-Barr virus-associated lymphoproliferative disease occurring in a patient with sarcoidosis treated by methotrexate and methylprednisolone.
Topics: Anti-Inflammatory Agents; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Methylprednisolone; Middle Aged; Sarcoidosis, Pulmonary | 2002 |
Tailored chemotherapy for malignant lymphoma arising in the setting of posttransplant lymphoproliferative disorder after solid organ transplantation.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Kidney Transplantation; Lung Neoplasms; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Postoperative Complications; Prednisone; Remission Induction; Stomach Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2002 |
Epstein-Barr virus-associated lymphoproliferative disorder in a patient with rheumatoid arthritis on methotrexate and rofecoxib: idiosyncratic reaction or pharmacogenetics?
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Drug Interactions; Epstein-Barr Virus Infections; Female; Humans; Lactones; Lymphoproliferative Disorders; Methotrexate; Sulfones | 2002 |
Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas.
Topics: Epstein-Barr Virus Infections; Graft Rejection; Herpesvirus 4, Human; HIV Infections; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Immunotherapy; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Methotrexate; Transplantation; Virus Latency | 2005 |
[Effective treatment for a methotrexate-associated lymphoproliferative disorder with R-CHOP following administration of rituximab].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Opportunistic Infections; Prednisolone; Rituximab; Vincristine | 2005 |
Reduced-intensity allogeneic haemopoietic stem cell transplantation induces durable responses in patients with chronic B-lymphoproliferative disorders.
Topics: Adolescent; Adult; Aged; B-Lymphocytes; Cyclosporine; Female; Filgrastim; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Recombinant Proteins; Remission Induction; Transplantation, Homologous | 2006 |
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Contraindications; Cyclosporine; Disease Progression; Disease Susceptibility; DNA, Neoplasm; Etanercept; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Gene Rearrangement, B-Lymphocyte, Light Chain; Genes, Immunoglobulin; Humans; Immunocompromised Host; Immunoglobulin G; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate; Neoplasm Proteins; Receptors, Tumor Necrosis Factor; Rituximab; Tumor Necrosis Factor-alpha | 2006 |
Methtrexate-associated lymphoproliferative disorders. A clinicopathological study of 13 Japanese cases.
Topics: Aged; Antimetabolites, Antineoplastic; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Humans; Immunohistochemistry; In Situ Hybridization; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Prevalence; RNA, Viral | 2006 |
Analysis of p53 and Bak gene mutations in lymphoproliferative disorders developing in rheumatoid arthritis.
Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; bcl-2 Homologous Antagonist-Killer Protein; Female; Humans; Immunohistochemistry; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Mutation; Phenotype; Prognosis; Tumor Suppressor Protein p53 | 2007 |
Methotrexate-induced lymphoproliferative disorder in a patient with Sézary syndrome.
Topics: Aged; Antimetabolites, Antineoplastic; Biopsy; Disease Progression; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphatic Diseases; Lymphoproliferative Disorders; Male; Methotrexate; Prognosis; Risk Factors; Sezary Syndrome | 2006 |
Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunoenzyme Techniques; Immunophenotyping; Immunosuppressive Agents; In Situ Hybridization; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Neoplasm Staging; Organ Transplantation; RNA, Viral; Survival Rate | 2007 |
Methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis presenting in the skin.
Topics: Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy, Needle; Facial Dermatoses; Female; Follow-Up Studies; Humans; Immunohistochemistry; Long-Term Care; Lymphoproliferative Disorders; Methotrexate; Risk Assessment | 2007 |
Lymphomatoid granulomatosis and diffuse alveolar damage associated with methotrexate therapy in a patient with rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Fatal Outcome; Humans; Immunosuppressive Agents; Lymphomatoid Granulomatosis; Lymphoproliferative Disorders; Male; Methotrexate; Pneumonia; Pulmonary Alveoli | 2007 |
Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Topics: ABO Blood-Group System; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; beta-Thalassemia; Blood Group Incompatibility; Busulfan; Child, Preschool; Cyclosporine; Epstein-Barr Virus Infections; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Plasma Exchange; Red-Cell Aplasia, Pure; Remission, Spontaneous; Retrospective Studies; Risk Factors; Rituximab; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2007 |
[2-year complete remission after withdrawal of methotrexate in a rectal methotrexate-associated diffuse large B-cell lymphoma].
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Gene Rearrangement; Genes, Immunoglobulin Heavy Chain; Herpesvirus 4, Human; Humans; Immunocompromised Host; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Rectal Neoplasms; Remission Induction; Time Factors | 2007 |
Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients.
Topics: Adrenal Cortex Hormones; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Immunotherapy; Infections; Injections, Spinal; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Male; Methotrexate; Methylprednisolone; Recurrence; Retrospective Studies; Treatment Outcome | 2007 |
Methotrexate-associated lymphoproliferative disorder masquerading as interstitial lung disease.
Topics: Antirheumatic Agents; B-Lymphocytes; Female; Humans; Lung Diseases, Interstitial; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Radionuclide Imaging; Thorax | 2007 |
Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Methotrexate; Remission Induction; Skin Diseases | 2007 |
Reversible infliximab-related lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Glucocorticoids; Humans; Immunocompromised Host; Infliximab; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Prednisolone | 2008 |
High-dose methotrexate with citrovorum factor rescue for patients with refractory lymphoproliferative disorders.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Humans; Leucovorin; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged | 1980 |
Aggressive treatment for postcardiac transplant lymphoproliferation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Life Tables; Lymphoproliferative Disorders; Male; Mechlorethamine; Methotrexate; Middle Aged; Multiple Organ Failure; Postoperative Complications; Prednisone; Procarbazine; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 1995 |
Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection.
Topics: Arthritis, Rheumatoid; B-Lymphocytes; Burkitt Lymphoma; Female; Herpesvirus 4, Human; Humans; Lymph Nodes; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Viral Matrix Proteins | 1995 |
Reversible lymphomas.
Topics: Arthritis, Rheumatoid; Cytomegalovirus; Herpesvirus 4, Human; Humans; Lymphoma; Lymphoproliferative Disorders; Methotrexate | 1993 |
Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anemia; Antimetabolites, Antineoplastic; Aspartate Aminotransferases; Dermatologic Agents; Diarrhea; Drug Administration Schedule; Fatigue; Female; Follow-Up Studies; Humans; Ki-1 Antigen; Liver Cirrhosis; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Peripheral; Lymphomatoid Papulosis; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Nausea; Remission Induction; Skin Diseases; Skin Neoplasms; Weight Loss | 1996 |
Epstein-Barr virus and lymphoproliferation in methotrexate-treated rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Blotting, Southern; Female; Herpesvirus 4, Human; Humans; Immunohistochemistry; In Situ Hybridization; Lymphoproliferative Disorders; Methotrexate; Middle Aged | 1996 |
Transplantation of allogeneic peripheral blood progenitor cells--the EBMT experience.
Topics: Adolescent; Adult; Blood Donors; Busulfan; Child; Child, Preschool; Cyclosporine; Erythropoietin; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Leukemia; Lymphoma; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Prednisolone; Whole-Body Irradiation | 1996 |
Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy.
Topics: Aged; Antirheumatic Agents; Child; Female; Follow-Up Studies; Herpesviridae Infections; Herpesvirus 4, Human; Hodgkin Disease; Humans; Immunophenotyping; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Reed-Sternberg Cells; Tumor Virus Infections | 1996 |
Clonality of Epstein-Barr virus in lymphoproliferative disorders in patients treated with immunosuppressive therapy for rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Methotrexate | 1996 |
[Allogenic transplant of non-manipulated hematopoietic progenitor peripheral blood cells. Spanish experience of 79 cases. Allo-Peripheral Blood Transplantation Group].
Topics: Adolescent; Adult; Bone Marrow Diseases; Female; Graft Rejection; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Multiple Myeloma; Transplantation Conditioning; Transplantation, Homologous | 1997 |
Methotrexate induced lymphoma?
Topics: Antirheumatic Agents; Carcinogenicity Tests; Folic Acid Antagonists; Humans; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Methotrexate; Mutagenicity Tests; Rheumatic Diseases | 1998 |
Hodgkin's disease and B cell lymphoproliferation in rheumatoid arthritis patients treated with methotrexate: a kinetic study of lymph node changes.
Topics: Aged; Arthritis, Rheumatoid; Biopsy; Female; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged | 1999 |
Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclosporine; Cytarabine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoproliferative Disorders; Male; Melphalan; Methotrexate; Middle Aged; Podophyllotoxin; Transplantation Conditioning; Transplantation, Homologous | 2000 |
A vessel runs through it.
Topics: Humans; Immunosuppressive Agents; Lymphocytes; Lymphoproliferative Disorders; Methotrexate; Skin; Skin Diseases; Vasculitis | 2000 |
Methotrexate-treated arthritis and lymphoproliferative disease--coincidence only?
Topics: Aged; Arthritis; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged | 2001 |
Diffuse large B-cell non-Hodgkin's lymphoma in a patient with autoimmune lymphoproliferative syndrome.
Topics: Adult; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autoimmune Diseases; Axilla; Biomarkers; Bone Marrow; fas Receptor; Humans; Immunohistochemistry; Immunosuppressive Agents; Lymph Nodes; Lymphoma, B-Cell; Lymphoproliferative Disorders; Male; Methotrexate; Mutagenesis, Insertional; Neuropeptides; Polymerase Chain Reaction; Receptors, Tumor Necrosis Factor; T-Lymphocytes | 2001 |
Coexistent Felty's syndrome and palindromic rheumatism.
Topics: Cell Count; Diagnosis, Differential; Felty Syndrome; Humans; Lymphocytes; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Phenotype; Rheumatic Diseases | 1991 |
Complications of immunosuppression associated with weekly low dose methotrexate.
Topics: Aged; Aged, 80 and over; Arthritis, Psoriatic; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Female; Herpes Zoster; Humans; Immunosuppression Therapy; Incidence; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Pneumonia, Pneumocystis | 1991 |